1. Pyruvate kinase purified from the hepatopancreas of Carcinus maenas exhibited sigmoidal saturation kinetics with respect to the substrate phosphoenolpyruvate in the absence of the allosteric activator fructose 1,6-bisphosphate, but normal hyperbolic saturation was seen in the presence of this activator. The activation appears to be the result of a decrease in the SO.5 exhibiting a near-maximal activity in the absence of activator. 4. L-Alanine inhibited the enzyme, but homotropic co-operative interactions were only seen with a cruder (lOOOOOg supernatant) enzyme preparation. The inhibition by alanine could be overcome by increasing the concentration of either phosphoenolpyruvate or fructose 1,6-bisphosphate, although increasing the L-alanine concentration did not appear to be able to reverse the activation by fructose 1,6-bisphosphate. 5. In the presence of a low concentration of phosphoenolpyruvate, increasing the concentration of the product, ATP, caused an initial increase in enzyme activity, followed by an inhibitory phase. In the presence of either fructose 1,6-bisphosphate or L-alanine only inhibition was seen. 6. The inhibition by ATP could not be completely reversed by fructose 1,6-bisphosphate.
Fructose 1,6-bisphosphate stimulates pyruvate kinase (EC 2.7.1.40) from yeast and rat liver (Taylor & Bailey, 1967) with kinetics characteristic of allosteric activation. The allosteric mammalian liver enzyme has been shown to be distinct from the non-allosteric enzyme isolated from skeletal muscle, on the basis of their chromatographic, electrophoretic, immunological and kinetic properties (Tanaka et al., 1967) . In general the liver-type enzyme predominates in gluconeogenic tissues (Tanaka et al., 1967) , where the regulatory enzyme appears to be involved in the metabolic control of the switch between glycolysis and gluconeogenesis (Llorente et al., 1970; Soling et al., 1973) . Studies on the kinetic properties of the enzymes from mammalian liver (Rozengurt et al., 1969) and from yeast (Haeckel et al., 1968; Wieker & Hess, 1971) have shown that most of the observed effects can be explained by the concerted model of allosteric control (Monod et al., 1965) , where there is a transition between two states of the enzyme with different affinities for the substrates. There are some discrepancies to this model. Thus the allosteric control by phosphoenolpyruvate, fructose 1,6-bisphosphate, ATP and alanine is not abolished by saturating with K+ (Rozengurt et al., 1969; Jiminez de Asua et al., 1970) , findings that can be accommodated by the Vol. 165 sequential conformational-change model of Koshland et al. (1966) .
The hepatopancreas of the common shore crab Carcinus maenas has been demonstrated to be a gluconeogenic tissue (Toghrol, 1969) , and, in common with mammalian gluconeogenic tissues, contains a high activity of pyruvate kinase, but a relatively low activity of pyruvate carboxylase (Giles et al., 1975) . Pyruvate kinase from this tissue has been extensively purified (Giles et al., 1976a) .
Therp is some evidence that in hepatopancreas, this enzyme is a site for metabolic control. The massaction ratio of 0.53 calculated from the tissue concentrations of substrates and products (Giles et al., 1976b) is considerably lower than the equilibrium constant of this reaction, 2000 -20000 (McQuate & Utter, 1959 Krimsky, 1959) , which indicates a nonequilibrium reaction in the cell. In addition, preliminary studies have shown that fructose 1,6-bisphosphate will activate the enzyme, that L-alanine and ATP will inhibit it, and that in the presence of approximately physiological concentrations of these substrates and effectors the activity of the enzyme is decreased to 5-10% of the total potential activity (Giles et al., 1975 
Animals
The common shore crab Carcinus maenas was collected locally from Southampton Water and kept at 10-12°C in an aquarium containing circulating sea water collected from the same source.
Methods
Assay of pyruvate kinase. The assay system used was as previously described (Giles et al., 1976a) , except that 50mM-dipotassium glycerol 1-phosphate was included. This salt served both as the source of K+ (100mM) and, in conjunction with sufficient MgSO4, buffered the Mg2+ concentration at 8mm (Boyer, 1969) . The amount of MgSO4 required was calculated by using the known dissociation constants of the chelating species (Boyer, 1969 (Brinley & Scarpa, 1975 (Adam, 1963) , phosphoenolpyruvate (Czok & Eckert, 1963) , ATP (Lamprecht & Trautschold, 1963) and fructose 1,6-bisphosphate (Bucher & Hohorst, 1963) (Rozengurt et al., 1969) and yeast (Haeckel et al., 1968) enzymes, is consistent with a conformational change of the 'K' type as defined by Monod et al. (1965) . The binding of fructose 1,6-bisphosphate has no effect on the binding of ADP, hyperbolic saturation kinetics occurring in the presence and absence of the activator. This is unlike the yeast enzyme, where ADP also exhibits positive homotropic kinetics (Haeckel et al., 1968) . Variation of the concentration of fructose 1,6-bisphosphate in the presence of a low concentration of phosphoenolpyruvate ( Fig. lb) shows a hyperbolic saturation of the enzyme with the activator. In the conditions quoted the apparent activation constant for fructose 1,6-bisphosphate was 2.1 pM. Vol. 165
In the experiments described above, ATP, a known inhibitor of the enzyme, was absent. Experiments were therefore designed to investigate the nature of the activations by fructose 1 ,6-bisphosphate and phosphoenolpyruvate in the presence of ATP.
Measurement of the pyruvate kinase activity at a constant adenine nucleotide concentration of 1 mM (approximately physiological for hepatopancreas), but with a variation in the [ATP]/[ADP] ratio, showed that the positive homotropic co-operativity with respect to phosphoenolpyruvate was lost as the concentration of ATP increased (Fig. 2a) . Repeating the experiment in the presence of 500pM-fructose 1,6-bisphosphate showed that the positive homotropic interactions of phosphoenolpyruvate with the enzyme were absent at all times, but that the s0. (Fig. 3) .
Inhibition by L-alanine The actions of the negative effector L-alanine were reversed by increasing the concentration of either fructose 1,6-bisphosphate or phosphoenolpyruvate (Fig. 4) . The positive effector fructose 1,6-bisphosphate caused a shift of the I0.5 (alanine) (inhibitor concentration giving half-maximal inhibition) towards higher concentrations. The Hill plots of these data, in the modification of Jensen & Nester (1966) , show no homotropic interactions of alanine. This is not in agreement with the predictions of the concerted allosteric model, where the homotropic cooperativity of a negative modifier should be strengthened in the presence of a positive modifier. Llorente et al. (1970) , using a crude enzyme extract from rat liver, found significant differences in the effects of alanine from those found by Schoner et al. (1970) , who used a partially purified rat liver enzyme preparation. Subsequent investigations led Seubert & Schoner (1971) to suggest that a partial desensitization of the enzyme occurred on purification. It was reasonable therefore to investigate whether a similar phenomenon occurred with the C. maenas enzyme. Repeating the alanine-inhibition experiments, but with a fresh 100000g hepatopancreas supernatant as the enzyme source, showed that an increase in the concentration of the positive effector fructose 1,6-bisphosphate caused a strengthening of the homotropic interactions of alanine (Fig. 5) . The Hill coefficient increased from 0.85 in the absence, to 2.5 in the presence, of 3.3 uM-fructose 1,6-bisphosphate. centrations. Saturation with alanine did not completely reverse the activation caused by fructose 1,6-bisphosphate. Conversely, saturation with fructose 1,6-bisphosphate did reverse the inhibition by alanine.The different responses of the crude extract and purified enzyme are most unlikely to be due to the presence of extraneous ions. The assay conditions were identical, except for the two enzyme sources, with the only possible extraneous ions being those in the cell extract. As the overall dilution of this in the assay medium was greater than 1: 3000 this would 8 10 effectively eliminate any effects due to extraneous ions.
Repeating the experiments in the presence ofa 1 mM te and phosphoor 2mM total nucleotide pool, with an [ATP]/[ADP] n of the purified ratio of 7:3, showed that alanine was inhibitory. centration indicated that there was always a finite rate. Addition of a low concentration of fructose 1,6-bisphosphate to the crude enzyme affected the catalytic activity that remained at high alanine conVol. 165 (Fig. 6) . Initially, the enzyme activity increased as the ATP concentration rose, until a maximal doubling in enzyme activity was measured at 2mM-ATP. This phase of activation was followed by inhibition. In the presence of either fructose 1,6-bisphosphate or Lalanine no initial stimulation was seen, only the inhibitory phase, and the Hill coefficients for the ATP inhibition were 1. A decrease in the '0.5 (ATP) occurred in the presence of either alanine (IO.5 = 2.8mM) or fructose 1,6-bisphosphate (Io.5 = 0.62mM) compared with that seen for the inhibitory phase obtained in the absence of effectors. The activation of the C. maenas enzyme is similar to that observed for the yeast enzyme, where a stimulation in activity was observed in the presence of low concentrations (2.5mM) of ATP (Haeckel et al., 1968) .
Activation by phosphoenolpyruvate in the presence of A TP and L-alanine
The interactions of phosphoenolpyruvate with the enzyme in a crude homogenate in the presence of the other allosteric modifiers of the enzyme are shown in Fig. 7 . The results show that as the concentration of phosphoenolpyruvate is increased, the enzyme activity tends to the same value, irrespective of the presence of alanine or fructose 1,6-bisphosphate. [Phosphoenolpyruvate] (pM) Fig. 7 Activation byfructose 1,6-bisphosphate in thepresence of ATP and L-alanine
The effect of fructose 1 ,6-bisphosphate on the 1000OOg-supernatant enzyme at a constant concentration of phosphoenolpyruvate (144pM) and in the presence of ATP and L-alanine are shown in Fig. 8 . In the absence of ATP and alanine, fructose 1,6-bisphosphate activated the enzyme with kinetics that exhibit positivehomotropicco-operativity. The inhibition observed on addition of ATP to give an [ATP]/[ADP] ratio of 7:3 could not be completely reversed by increasing the fructose 1,6-bisphosphate concentrations. At the same time, however, the positive cooperative interactions of fructose 1,6-bisphosphate with the enzyme increased as shown by the increasing Hill coefficient. Addition of alanine in the presence of ATP produced an additional inhibition that depended on the amount ofthe amino acid added. Increasing the concentration of the fructose 1 ,6-bisphosphate showed that saturation with fructose 1 ,6-bisphosphate was able to reverse the alanine inhibition, althoughthe enzyme activity measured was less than that in the absence of ATP. In the presence of alanine, the enzyme appears to lose some of its co-operative interactions with fructose 1,6-bisphosphate, as seen by the decrease in the Hill coefficients.
Discussion
The first steady-state kinetic studies reported in the literature for the allosteric pyruvate kinases (Haeckel et al., 1968; Rozengurt et al., 1969) were explained by using the concerted model of allosteric control as suggested by Monod etal. (1965) . Theresults ofa more rigorous analysis of the interactions of fructose 1,6-bisphosphate, phosphoenolpyruvate and ATP with the yeast enzyme (Hess et al., 1973) could not be adequately explained by this model, and the formation of a hybrid polymeric state of the enzyme, participating in parallel to the R-T equilibrium of the Monod et al. (1965) model, was proposed. The inclusion of this hybrid invalidated the symmetry assumption of the Monod et al. (1965) model and the mechanism proposed became a simple example of the sequential-conformational-change model of Koshland et al. (1966) .
The theories of allosteric interactions (Monod et al., 1965; Koshland et al., 1966) as developed explain the binding properties of a protein. To date no direct physical binding studies have been conducted on the C. maenas pyruvate kinase from hepatopancreas. One reason for this, in addition to the technical difficulties that exist in obtaining sufficient protein, is that the results of such experiments would not be unambiguous, since it has been demonstrated that the kinetic properties of the enzyme in a crude tissue extract and after purification are different. Since the homogeneous protein is required for binding studies it is possible that the results would be different from those for the native enzyme. We were therefore compelled to use a kinetic approach to study the allosteric interactions of this enzyme. Such studies assume that the initial rate of the enzyme reaction is directly proportional to the fractional saturation of the enzyme. If this assumption is not valid the data become very difficult, if not impossible, to analyse. Nevertheless much of the Vol. 165 information gathered on allosteric proteins in the literature has been implied from kinetic studies.
The change in the kinetic properties of the C. maenas enzyme on purification is intriguing and gives some credence to the suggestion that the sigmoidal kinetics observed are the result of subunit interactions. Irrespective of its purity the enzyme always showed positive homotropic kinetics with respect to phosphoenolpyruvate, and fructose 1,6-bisphosphate always activated the enzyme. The purified enzyme, however, gave hyperbolic saturation kinetics for the fructose 1,6-bisphosphate binding, whereas the crude enzyme gave a sigmoidal response to this ligand. Similar observations were made for the binding of the inhibitor L-alanine. That the homotropic co-operative interactions of fructose 1,6-bisphosphate and alanine alone were lost suggests that it is the transmission of the site-site interactions that are altered in the purified enzyme. These results suggest that phosphoenolpyruvate exerts its co-operative effect at a different site from that for fructose 1,6-bisphosphate.
A simple model to explain the co-operative kinetics of phosphoenolpyruvate binding involves the substrate binding at the active site and triggering a conformational change from this site. The apparently anomalous effects of ATP can be explained, without the assumption of a second allosteric binding site, if this ligand can induce a conformational change comparable with that produced by phosphoenolpyruvate by its binding to the active site (it is a product of the reaction). From this hypothesis it can be predicted that at a low concentration of phosphoenolpyruvate, and in the absence of other activators, increasing the concentration of ATP will cause an increase in enzyme activity as a result of the favourable subunit interactions. Increasing the concentration of ATP past an optimal value will cause a fall in the enzyme activity, as it acts as a product inhibitor. In the presence of the allosteric activator the enzyme will already be in the fully activated state and ATP will only show inhibition. Further, because of the nature of this inhibition, saturation with fructose 1 ,6-bisphosphate will not reverse it. In the presence of a high concentration ofATP the enzyme will be in the fully activated state and will not show an increase in enzyme activity on adding the allosteric activator fructose 1,6-bisphosphate. All these predictions were verified experimentally with the C. maenas enzyme. It appears unnecessary therefore to invoke a second inhibitory binding site for ATP to explain its actions. If this hypothesis is correct, it implies that the y-phosphate group of ATP is involved in triggering the conformational change of the enzyme, as ADP exhibits no co-operative effects.
It is possible to determine the allosteric constants of an enzyme that can be described by the Monod et al. (1965) model by using the procedure developed by Blangy et al. (1968) ifthe affinity ofthe two conformers of the enzyme for the substrate can be measured. The procedure has been applied to yeast pyruvate kinase (Hess et al., 1973) , by using fructose 1,6-bisphosphate and ATP to drive the enzyme into the two conformers, from which the non-exclusive binding constant was measured. It has been reported, however, that low concentrations of ATP activate the yeast enzyme (Haeckel et al., 1968) . If this activation occurs in a similar way to that suggested for the C. maenas enzyme, it is possible that the reported values of the allosteric constants may need revision, as the ATP could be causing the transition to the highaffinity, rather than the low-affinity, state.
Alanine is an inhibitor of the mammalian type-L pyruvate kinases (Seubert et al., 1968) , but little detailed information is available about its interactions with the enzyme and the effects that it manifests on the steady-state kinetics of the enzyme. The actions of alanine on the activity of the C. maenas enzyme are more complicated than those of the other ligands investigated. In the absence of fructose 1,6-bisphosphate and ATP an apparent value of 0.85 was obtained for the Hill coefficient when the concentration of L-alanine was varied (Fig. 5) . If this value is a reliable estimate it would imply that the Monod et al. (1965) model is invalid for this enzyme, as negative homotropic co-operative interactions cannot be accommodated inthis model; that is the Hill coefficient must be equal to, or greater than, 1 (Dalziel & Engel, 1968) .
It is critical, therefore, to decide whether the Hill coefficient measured is significantly less than 1, as this will have important mechanistic implications. The value of the Hill coefficient was 0.85 when estimated by the method of Atkins (1973) , but was near 1 when estimated by the classical graphical method of analysis (Koshland, 1970) . This discrepancy arises from the different methods used to determine the enzyme activity at saturating concentrations of Lalanine, v,at., and in the error that exists in the difference between the inhibited (vi) and uninhibited (vo) rates. At low inhibitor concentrations this is a small difference between two large numbers, both of which are experimentally determined. Thus a large percentageerrormay be associated withthis difference, the percentage error getting smaller as the difference gets larger. Significant error may be introduced, therefore, at both the low inhibitor concentrations (due to that in vo-v1) and at high inhibitor concentrations (due to that in vsa,.). Consequently the value of the slope of the Hill plot may show significant variation, depending on the method of analysis. The data available at the moment therefore do not indicate that the value of this Hill coefficient is significantly less than 1.
In the eventuality that this value is less than 1 the negative co-operativity can be explained either by the 'pseudoconservative' model of Viratelle & Seydoux (1975) or the sequential conformational-change model of Koshland et al. (1966) . Negative cooperativity is seen in the latter model when the binding of a ligand hinders the binding of subsequent molecules of the ligand to the enzyme. Two welldocumented enzymes that have been suggested to have this type of mechanism are glyceraldehyde 3-phosphate dehydrogenase (Conway & Koshland, 1968) and glutamate dehydrogenase (Engel & Dalziel, 1969) .
Another anomalous observation of the alanineinhibition experiments is that the alanine inhibition can be reversed by saturating with fructose 1,6-bisphosphate, whereas alanine will not reverse the activation by fructose 1,6-bisphosphate. A partial inhibition is occurring. Incomplete antagonism between allosteric activators and allosteric inhibitors has been reported for several enzymes and is well documented for Escherichia coli L-threonine deaminase (Changeux, 1962) . Partial inhibitions are difficult to explain and no obvious explanation for the effects of the C. maenas enzyme can be suggested on the basis of the present results. The partial inhibition of L-threonine deaminase has been suggested to be due to a preferential non-exclusive binding of either or both of the ligands involved to the enzyme (Rubin & Changeux, 1966) . The results for the C. maenas enzyme may be explained by a non-exclusive binding of the substrate that occurs in the presence of alanine, as extrapolation of the enzyme activity obtained to a saturating concentration of alanine gives a value greater than zero. An alternative explanation for this observation requires the existence of two types of binding site for fructose 1,6-bisphosphate. At one type, L-alanine can compete with the fructose 1,6-bisphosphate binding, whereas at the other only the activator can bind.
The physiological implications of the results presented are difficult to assess. The physical nature of the tissue and the fact that C. maenas possesses an open circulation means that perfusion studies of hepatopancreas are not feasible. As a result no reliable estimates of the rates of the glycolytic or gluconeogenic fluxes are available for this tissue. This leaves only a scant idea of the kind of enzymeactivity changes that may occur physiologically. It is evident, however, that at physiological concentrations of all the substrates and effectors the enzyme activity is likely to be considerably less than that obtained in optimal conditions (Giles et al., 1976b) .
The present studies can offer a possible explanation for the previous observation (Giles et al., 1976b) that fructose 1,6-bisphosphate only activates the enzyme at a physiological [ATP]/[ADP] ratio in the presence of alanine. In the absence of alanine, the ATP favours formation of the high-affinity state of the enzyme, the form on which fructose 1 , 6-bisphosphate 1977 has no action. In the presence of alanine, however, some of the enzyme may be in a low-affinity conformational state, the form which fructose 1,6-bisphosphate can activate. This finding illustrates the caution that must be exercised before the results of experiments in vitro can be meaningfully transposed to the situation in vivo. The simultaneous presence of modifiers can alter the response of an enzyme to variation of one of the ligands. The results in the present paper, however, do indicate that, in the presence of the modifiers studied, the enzyme activity can vary over a relatively wide range if there are concerted changes in the concentrations of the controlling ligands around their measured total tissue concentrations.
